Author:
Schwaibold Hartwig,Huland Edith,Heinzer Hans,Schwul�ra Udo,Huland Hartwig
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference14 articles.
1. Bradley LM, Duncan DD, Tonkonogy S, Swain SL (1991) Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14?, CD45 RB? helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4, and interferon gamma. J Exp Med 174:547?559
2. Heinzer H, Huland H, Huland E (1990) Activated eosinophil leucocytes in interleukin-2 treated patients: evidence for a new antitumor effector mechanism (abstract). J Cancer Res Clin Oncol 369
3. Herr H (1987) Conservative management of muscle-infiltrating bladder cancer: prospective Experience. J Urol 138:1162?1163
4. Huland E, Huland H (1989) Local continuous high dose interleukin-2: a new therapeutic model for the treatment of advanced bladder carcinoma. Cancer Res 49:5469?5474
5. Huland E, Huland H (1992) Tumor associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells. J Cancer Res Clin Oncol 118:463?467
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献